Percutaneous biopsy of portal vein thrombus: A new staging technique for hepatocellular carcinoma

G. D. Dodd, B. I. Carr

Research output: Contribution to journalArticle

48 Citations (Scopus)

Abstract

OBJECTIVE. Accurate staging of hepatocellular carcinoma is necessary to determine appropriate treatment. In particular, neoplastic invasion of the portal vein is a contraindication for hepatic resection or transplantation. Unfortunately, imaging cannot always differentiate benign from malignant portal vein thrombi. We therefore undertook a study to determine the efficacy and safety of sonographically guided percutaneous biopsy of portal vein thrombi as a staging technique for patients with hepatocellular carcinoma. SUBJECTS AND METHODS. We performed percutaneous biopsy of portal vein thrombi in 12 men and two women (43-76 years old) who were being considered for hepatic resection or transplantation. All of the patients had hepatic cirrhosis and 13 had histologically proved intrahepatic hepatocellular carcinoma. Biopsies were performed under continuous color Doppler sonographic guidance by using 20-gauge aspiration needles with occlusive stylets. Each needle was positioned with its tip embedded in the thrombus before the stylet was removed. During aspiration, the needle was carefully controlled to keep its tip within the lumen of the portal vein. To evaluate for possible false- positive results, an additional identical needle was passed in and out of only the hepatic parenchyma in five patients. RESULTS. Adequate specimens were obtained in all 14 patients. Twelve specimens contained malignant hepatocytes, and two contained benign thrombi. One of the benign thrombi in a patient who had a 3-cm hepatocellular carcinoma of the parenchyma was confirmed by examining the resected liver after transplantation. The other patient who had a benign thrombus had no clinical or imaging evidence of hepatocellular carcinoma. No complications associated with biopsy occurred. None of the control needles contained hepatocytes. The patients' discomfort during biopsy was approximately the same as the discomfort experienced during previous liver biopsies. The average length of the procedure was 20 min. CONCLUSION. Sonographically guided percutaneous biopsy of portal vein thrombi is a safe, accurate, useful, and well-tolerated diagnostic procedure for the staging of hepatocellular carcinoma.

Original languageEnglish
Pages (from-to)229-233
Number of pages5
JournalAmerican Journal of Roentgenology
Volume161
Issue number2
Publication statusPublished - 1993

Fingerprint

Portal Vein
Hepatocellular Carcinoma
Thrombosis
Biopsy
Needles
Liver
Hepatocytes
Transplantation
Liver Cirrhosis
Liver Transplantation
Color
Safety

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Radiological and Ultrasound Technology

Cite this

Percutaneous biopsy of portal vein thrombus : A new staging technique for hepatocellular carcinoma. / Dodd, G. D.; Carr, B. I.

In: American Journal of Roentgenology, Vol. 161, No. 2, 1993, p. 229-233.

Research output: Contribution to journalArticle

@article{305d61e8028e4a6b813042db8a669a9a,
title = "Percutaneous biopsy of portal vein thrombus: A new staging technique for hepatocellular carcinoma",
abstract = "OBJECTIVE. Accurate staging of hepatocellular carcinoma is necessary to determine appropriate treatment. In particular, neoplastic invasion of the portal vein is a contraindication for hepatic resection or transplantation. Unfortunately, imaging cannot always differentiate benign from malignant portal vein thrombi. We therefore undertook a study to determine the efficacy and safety of sonographically guided percutaneous biopsy of portal vein thrombi as a staging technique for patients with hepatocellular carcinoma. SUBJECTS AND METHODS. We performed percutaneous biopsy of portal vein thrombi in 12 men and two women (43-76 years old) who were being considered for hepatic resection or transplantation. All of the patients had hepatic cirrhosis and 13 had histologically proved intrahepatic hepatocellular carcinoma. Biopsies were performed under continuous color Doppler sonographic guidance by using 20-gauge aspiration needles with occlusive stylets. Each needle was positioned with its tip embedded in the thrombus before the stylet was removed. During aspiration, the needle was carefully controlled to keep its tip within the lumen of the portal vein. To evaluate for possible false- positive results, an additional identical needle was passed in and out of only the hepatic parenchyma in five patients. RESULTS. Adequate specimens were obtained in all 14 patients. Twelve specimens contained malignant hepatocytes, and two contained benign thrombi. One of the benign thrombi in a patient who had a 3-cm hepatocellular carcinoma of the parenchyma was confirmed by examining the resected liver after transplantation. The other patient who had a benign thrombus had no clinical or imaging evidence of hepatocellular carcinoma. No complications associated with biopsy occurred. None of the control needles contained hepatocytes. The patients' discomfort during biopsy was approximately the same as the discomfort experienced during previous liver biopsies. The average length of the procedure was 20 min. CONCLUSION. Sonographically guided percutaneous biopsy of portal vein thrombi is a safe, accurate, useful, and well-tolerated diagnostic procedure for the staging of hepatocellular carcinoma.",
author = "Dodd, {G. D.} and Carr, {B. I.}",
year = "1993",
language = "English",
volume = "161",
pages = "229--233",
journal = "American Journal of Roentgenology",
issn = "0361-803X",
publisher = "American Roentgen Ray Society",
number = "2",

}

TY - JOUR

T1 - Percutaneous biopsy of portal vein thrombus

T2 - A new staging technique for hepatocellular carcinoma

AU - Dodd, G. D.

AU - Carr, B. I.

PY - 1993

Y1 - 1993

N2 - OBJECTIVE. Accurate staging of hepatocellular carcinoma is necessary to determine appropriate treatment. In particular, neoplastic invasion of the portal vein is a contraindication for hepatic resection or transplantation. Unfortunately, imaging cannot always differentiate benign from malignant portal vein thrombi. We therefore undertook a study to determine the efficacy and safety of sonographically guided percutaneous biopsy of portal vein thrombi as a staging technique for patients with hepatocellular carcinoma. SUBJECTS AND METHODS. We performed percutaneous biopsy of portal vein thrombi in 12 men and two women (43-76 years old) who were being considered for hepatic resection or transplantation. All of the patients had hepatic cirrhosis and 13 had histologically proved intrahepatic hepatocellular carcinoma. Biopsies were performed under continuous color Doppler sonographic guidance by using 20-gauge aspiration needles with occlusive stylets. Each needle was positioned with its tip embedded in the thrombus before the stylet was removed. During aspiration, the needle was carefully controlled to keep its tip within the lumen of the portal vein. To evaluate for possible false- positive results, an additional identical needle was passed in and out of only the hepatic parenchyma in five patients. RESULTS. Adequate specimens were obtained in all 14 patients. Twelve specimens contained malignant hepatocytes, and two contained benign thrombi. One of the benign thrombi in a patient who had a 3-cm hepatocellular carcinoma of the parenchyma was confirmed by examining the resected liver after transplantation. The other patient who had a benign thrombus had no clinical or imaging evidence of hepatocellular carcinoma. No complications associated with biopsy occurred. None of the control needles contained hepatocytes. The patients' discomfort during biopsy was approximately the same as the discomfort experienced during previous liver biopsies. The average length of the procedure was 20 min. CONCLUSION. Sonographically guided percutaneous biopsy of portal vein thrombi is a safe, accurate, useful, and well-tolerated diagnostic procedure for the staging of hepatocellular carcinoma.

AB - OBJECTIVE. Accurate staging of hepatocellular carcinoma is necessary to determine appropriate treatment. In particular, neoplastic invasion of the portal vein is a contraindication for hepatic resection or transplantation. Unfortunately, imaging cannot always differentiate benign from malignant portal vein thrombi. We therefore undertook a study to determine the efficacy and safety of sonographically guided percutaneous biopsy of portal vein thrombi as a staging technique for patients with hepatocellular carcinoma. SUBJECTS AND METHODS. We performed percutaneous biopsy of portal vein thrombi in 12 men and two women (43-76 years old) who were being considered for hepatic resection or transplantation. All of the patients had hepatic cirrhosis and 13 had histologically proved intrahepatic hepatocellular carcinoma. Biopsies were performed under continuous color Doppler sonographic guidance by using 20-gauge aspiration needles with occlusive stylets. Each needle was positioned with its tip embedded in the thrombus before the stylet was removed. During aspiration, the needle was carefully controlled to keep its tip within the lumen of the portal vein. To evaluate for possible false- positive results, an additional identical needle was passed in and out of only the hepatic parenchyma in five patients. RESULTS. Adequate specimens were obtained in all 14 patients. Twelve specimens contained malignant hepatocytes, and two contained benign thrombi. One of the benign thrombi in a patient who had a 3-cm hepatocellular carcinoma of the parenchyma was confirmed by examining the resected liver after transplantation. The other patient who had a benign thrombus had no clinical or imaging evidence of hepatocellular carcinoma. No complications associated with biopsy occurred. None of the control needles contained hepatocytes. The patients' discomfort during biopsy was approximately the same as the discomfort experienced during previous liver biopsies. The average length of the procedure was 20 min. CONCLUSION. Sonographically guided percutaneous biopsy of portal vein thrombi is a safe, accurate, useful, and well-tolerated diagnostic procedure for the staging of hepatocellular carcinoma.

UR - http://www.scopus.com/inward/record.url?scp=0027200787&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027200787&partnerID=8YFLogxK

M3 - Article

C2 - 8392785

AN - SCOPUS:0027200787

VL - 161

SP - 229

EP - 233

JO - American Journal of Roentgenology

JF - American Journal of Roentgenology

SN - 0361-803X

IS - 2

ER -